Does SIRUKUMAB Cause Mobility decreased? 516 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 516 reports of Mobility decreased have been filed in association with SIRUKUMAB. This represents 38.4% of all adverse event reports for SIRUKUMAB.
516
Reports of Mobility decreased with SIRUKUMAB
38.4%
of all SIRUKUMAB reports
394
Deaths
381
Hospitalizations
How Dangerous Is Mobility decreased From SIRUKUMAB?
Of the 516 reports, 394 (76.4%) resulted in death, 381 (73.8%) required hospitalization, and 347 (67.2%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SIRUKUMAB. However, 516 reports have been filed with the FAERS database.
What Other Side Effects Does SIRUKUMAB Cause?
Off label use (798)
Drug ineffective (775)
Rheumatoid arthritis (663)
Nausea (656)
Pain (629)
Synovitis (623)
General physical health deterioration (619)
Rash (565)
Pericarditis (562)
Pemphigus (561)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which SIRUKUMAB Alternatives Have Lower Mobility decreased Risk?
SIRUKUMAB vs SITAGLIPTIN
SIRUKUMAB vs SOAP
SIRUKUMAB vs SODIUM
SIRUKUMAB vs SODIUM BICARBONATE
SIRUKUMAB vs SODIUM BICARBONATE\SODIUM